Ribonucleic acid purification

Journal of Chromatography A

Volumn 1355, Issue , 2014, Pages 1-14

  Martins, R ^a   Queiroz, J A ^a   Sousa, F ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Affinity chromatography; Amino acids; Isolation methods; Purification; RNA

Indexed keywords

AFFINITY CHROMATOGRAPHY; AMINO ACIDS; MOLECULAR BIOLOGY; PURIFICATION; RESEARCH;

ACID PURIFICATION; BIOLOGICAL COMPOUNDS; BIOLOGICAL DISCOVERIES; BIOPHARMACEUTICAL INDUSTRY; ISOLATION AND PURIFICATION; ISOLATION METHODS; MOLECULAR BIOLOGY ANALYSIS; PURIFICATION PROCESS;

RNA;

ARGININE; HISTIDINE; LITHIUM CHLORIDE; AMINO ACID; RNA;

AFFINITY CHROMATOGRAPHY; ANION EXCHANGE CHROMATOGRAPHY; BINDING AFFINITY; CHEMICAL EXTRACTION; ENZYME SPECIFICITY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; ION PAIRING REVERSED PHASE LIQUID CHROMATOGRAPHY; METHODOLOGY; MOLECULAR BIOLOGY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; RNA ANALYSIS; RNA ISOLATION; RNA PURIFICATION; RNA STRUCTURE; SOLID PHASE EXTRACTION; ANIMAL; CHEMISTRY; CHROMATOGRAPHY; ELECTROPHORESIS; ISOLATION AND PURIFICATION; PROCEDURES;

AMINO ACIDS; ANIMALS; CHROMATOGRAPHY; ELECTROPHORESIS; HUMANS; RNA;

EID: 84904302278     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2014.05.075     Document Type: Review

References (133)

1. Sharp P.A. The centrality of RNA. Cell 2009, 136:577-580.
2. Lehman N. RNA in evolution. Wiley Interdiscip. Rev. RNA 2010, 1:202-213.
3. Burnett J.C., Rossi J.J. RNA-based therapeutics: current progress and future prospects. Chem. Biol. 2012, 19:60-71.
4. Melnikova I. RNA-based therapies. Nat. Rev. Drug Discov. 2007, 6:863-864.
5. L. Guideline on Human Cell-Based Medicinal Products 2007, EMA, Great Britain. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003898.pdf.
6. B. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use 2001, EC, Belgium. http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_83_cons/dir2001_83_cons_20081230_en.pdf.
7. Kreiter S., Diken M., Selmi A., Tureci O., Sahin U. Tumor vaccination using messenger RNA: prospects of a future therapy. Curr. Opin. Immunol. 2011, 23:399-406.
8. Srivatsa S. Regulatory Challenges, European Biopharmaceutical Review Sping 2012.
9. U. Guidance for Industry: Consideration for plasmid DNA vaccines for infection disease indications. FDA.
10. Weide B., Garbe C., Rammensee H.G., Pascolo S. Plasmid DNA- and messenger RNA-based anti-cancer vaccination. Immunol. Lett. 2008, 115:33-42.
11. Srivatsa G.S. Handbook of Analysis of Oligonucleotides and Related Products 2011, 465-486. CRC Press, Boca Raton, FL. J.V. Bonilla, S.G. Srivatsa (Eds.).
12. Garrett R., Grisham C. Biochemistry 2008, 291-314. Cengage Learning.
13. Murray R.K., Granner D.K., Mayes P.A., Rodwell V.W. Harper' Biochemistry 2000, McGraw-Hill, USA.
14. Liang X., Kuhn H., Frank-Kamenetskii M.D. Monitoring single-stranded DNA secondary structure formation by determining the topological state of DNA catenanes. Biophys. J. 2006, 90:2877-2889.
15. Soll D., Nishimura S., Moore P. RNA 2001, Pergamon, Oxford.
16. Arraiano C.M., Andrade J.M., Domingues S., Guinote I.B., Malecki M., Matos R.G., Moreira R.N., Pobre V., Reis F.P., Saramago M., Silva I.J., Viegas S.C. The critical role of RNA processing and degradation in the control of gene expression. FEMS Microbiol. Rev. 2010, 34:883-923.
17. Sullenger B.A., Gilboa E. Emerging clinical applications of RNA. Nature 2002, 418:252-258.
18. Jahn C.E., Charkowski A.O., Willis D.K. Evaluation of isolation methods and RNA integrity for bacterial RNA quantitation. J. Microbiol. Methods 2008, 75:318-324.
19. Fleige S., Pfaffl M.W. RNA integrity and the effect on the real-time qRT-PCR performance. Mol. Aspects Med. 2006, 27:126-139.
20. Easton L.E., Shibata Y., Lukavsky P.J. Rapid, nondenaturing RNA purification using weak anion-exchange fast performance liquid chromatography. RNA 2010, 16:647-653.
21. McGinnis A.C., Chen B., Bartlett M.G. Chromatographic methods for the determination of therapeutic oligonucleotides. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2012, 883-884:76-94.
22. Bustin S.A., Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Tech. 2004, 15:155-166.
23. Scott L.G., Hennig M. RNA structure determination by NMR. Methods Mol. Biol. 2008, 452:29-61.
24. Doudna J.A. Preparation of homogeneous ribozyme RNA for crystallization. Methods Mol. Biol. 1997, 74:365-370.
25. Wittmann A., Suess B. Engineered riboswitches: expanding researchers' toolbox with synthetic RNA regulators. FEBS Lett. 2012, 586:2076-2083.
26. Lorenzi J., Trombone A., Rocha C., Almeida L., Lousada R., Malardo T., Fontoura I., Rossetti R., Gembre A., Silva A., Silva C., Coelho-Castelo A. Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis. BMC Biotechnol. 2010, 10:77.
27. Zeng Y., Wagner E.J., Cullen B.R. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 2002, 9:1327-1333.
28. Sherlin L.D., Bullock T.L., Nissan T.A., Perona J.J., Lariviere F.J., Uhlenbeck O.C., Scaringe S.A. Chemical and enzymatic synthesis of tRNAs for high-throughput crystallization. RNA 2001, 7:1671-1678.
29. Dunin-Horkawicz S., Czerwoniec A., Gajda M.J., Feder M., Grosjean H., Bujnicki J.M. MODOMICS: a database of RNA modification pathways. Nucleic Acids Res. 2006, 34:D145-D149.
30. Yu R.Z., Zhang H., Geary R.S., Graham M., Masarjian L., Lemonidis K., Crooke R., Dean N.M., Levin A.A. Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice. J. Pharmacol. Exp. Ther. 2001, 296:388-395.
31. Kyte J.A., Mu L., Aamdal S., Kvalheim G., Dueland S., Hauser M., Gullestad H.P., Ryder T., Lislerud K., Hammerstad H., Gaudernack G. Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene Ther. 2006, 13:905-918.
32. Chomczynski P., Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat. Protoc. 2006, 1:581-585.
33. Vomelova I., Vanickova Z., Sedo A. Methods of RNA purification. All ways (should) lead to Rome. Folia Biol. (Praha) 2009, 55:243-251.
34. Farrell R.E. Epigenetic Regulation and Epigenomics: Advances in Molecular Biology and Medicine 2012, 1-37. Wiley-VCH, Weinheim. R.A. Meyers (Ed.).
35. McGookin R. New Nucleic Acid Techniques 1988, 215-220. Humana Press. J. Walker (Ed.).
36. Warren W.J., Vella G. Principles and methods for the analysis and purification of synthetic deoxyribonucleotides by high-performance liquid chromatography. Mol. Biotechnol. 1995, 4:179-199.
37. Tan S.C., Yiap B.C. DNA, RNA, and protein extraction: the past and the present. J. Biomed. Biotechnol. 2009, 2009:574398.
38. Wen J., Legendre L.A., Bienvenue J.M., Landers J.P. Purification of nucleic acids in microfluidic devices. Anal. Chem. 2008, 80:6472-6479.
39. Chatterjee A., Mirer P.L., Zaldivar Santamaria E., Klapperich C., Sharon A., Sauer-Budge A.F. RNA isolation from mammalian cells using porous polymer monoliths: an approach for high-throughput automation. Anal. Chem. 2010, 82:4344-4356.
40. Nawrocki J. The silanol group and its role in liquid chromatography. J. Chromatogr. A 1997, 779:29-71.
41. Isailovic S., Li H.W., Yeung E.S. Adsorption of single DNA molecules at the water/fused-silica interface. J. Chromatogr. A 2007, 1150:259-266.
42. Cady N.C., Stelick S., Batt C.A. Nucleic acid purification using microfabricated silicon structures. Biosens. Bioelectron. 2003, 19:59-66.
43. Parida S.K., Dash S., Patel S., Mishra B.K. Adsorption of organic molecules on silica surface. Adv. Colloid Interface Sci. 2006, 121:77-110.
44. Mutiu A.I., Brandl C.J. RNA isolation from yeast using silica matrices. J. Biomol. Tech. 2005, 16:316-317.
45. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 1990, 28:495-503.
46. Poeckh T., Lopez S., Fuller A.O., Solomon M.J., Larson R.G. Adsorption and elution characteristics of nucleic acids on silica surfaces and their use in designing a miniaturized purification unit. Anal. Biochem. 2008, 373:253-262.
47. Laurell H., Iacovoni J.S., Abot A., Svec D., Maoret J.J., Arnal J.F., Kubista M. Correction of RT-qPCR data for genomic DNA-derived signals with ValidPrime. Nucleic Acids Res. 2012, 40:e51.
48. Knepp J.H., Geahr M.A., Forman M.S., Valsamakis A. Comparison of automated and manual nucleic acid extraction methods for detection of enterovirus RNA. J. Clin. Microbiol. 2003, 41:3532-3536.
49. Loens K., Bergs K., Ursi D., Goossens H., Ieven M. Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens. J. Clin. Microbiol. 2007, 45:421-425.
50. Price S.R., Ito N., Oubridge C., Avis J.M., Nagai K. Crystallization of RNA-protein complexes. I. Methods for the large-scale preparation of RNA suitable for crystallographic studies. J. Mol. Biol. 1995, 249:398-408.
51. Hagen F.S., Young E.T. Preparative polyacrylamide gel electrophoresis of ribonucleic acid. Identification of multiple molecular species of bacteriophage T7 lysozyme messenger ribonucleic acid. Biochemistry 1974, 13:3394-3400.
52. Lukavsky P.J., Puglisi J.D. Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides. RNA 2004, 10:889-893.
53. Kim I., McKenna S.A., Viani Puglisi E., Puglisi J.D. Rapid purification of RNAs using fast performance liquid chromatography (FPLC). RNA 2007, 13:289-294.
54. Kieft J.S., Batey R.T. A general method for rapid and nondenaturing purification of RNAs. RNA 2004, 10:988-995.
55. Pascolo S. Toll-Like Receptors (TLRs) and Innate Immunity 2008, 221-235. Springer, Berlin, Heidelberg. S. Bauer, G. Hartmann (Eds.).
56. Baker B.F., Lot S.S., Condon T.P., Cheng-Flournoy S., Lesnik E.A., Sasmor H.M., Bennett C.F. 2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem. 1997, 272:11994-12000.
57. Nilsen T.W. Selective precipitation of large RNAs. Cold Spring Harb. Protoc. 2012, 2012. pdb.prot072322.
58. Barlow J.J., Mathias A.P., Williamson R., Gammack D.B. A simple method for the quantitative isolation of undegraded high molecular weight ribonucleic acid. Biochem. Biophys. Res. Commun. 1963, 13:61-66.
59. Diaz-Ruiz J.R., Kaper J.M. Isolation of viral double-stranded RNAs using a LiCl fractionation procedure. Prep. Biochem. 1978, 8:1-17.
60. Romanovskaya A., Sarin L.P., Bamford D.H., Poranen M.M. High-throughput purification of double-stranded RNA molecules using convective interaction media monolithic anion exchange columns. J. Chromatogr. A 2013, 1278:54-60.
61. El-Sagheer A.H., Brown T. New strategy for the synthesis of chemically modified RNA constructs exemplified by hairpin and hammerhead ribozymes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15329-15334.
62. Maina A., Blackman B.A., Parronchi C.J., Morozko E., Bender M.E., Blake A.D., Sabatino D. Solid-phase synthesis, characterization and RNAi activity of branch and hyperbranch siRNAs. Bioorg. Med. Chem. Lett. 2013, 23:5270-5274.
63. Maroney P.A., Chamnongpol S., Souret F., Nilsen T.W. A rapid, quantitative assay for direct detection of microRNAs and other small RNAs using splinted ligation. RNA 2007, 13:930-936.
64. McKenna S.A., Kim I., Puglisi E.V., Lindhout D.A., Aitken C.E., Marshall R.A., Puglisi J.D. Purification and characterization of transcribed RNAs using gel filtration chromatography. Nat. Protoc. 2007, 2:3270-3277.
65. Cramer H., Finn K.J., Herzberg E. Handbook of Analysis of Oligonucleotides and Related Products 2011, 1-46. CRC Press, Boca Raton, FL. J.V. Bonilla, S.G. Srivatsa (Eds.).
66. Dickman M.J. Chromatography Today 2011, 22-26. http://www.chromatographytoday.com.
67. Gilar M. Analysis and purification of synthetic oligonucleotides by reversed-phase high-performance liquid chromatography with photodiode array and mass spectrometry detection. Anal. Biochem. 2001, 298:196-206.
68. Chionh Y.H., Ho C.H., Pruksakorn D., Ramesh Babu I., Ng C.S., Hia F., McBee M.E., Su D., Pang Y.L., Gu C., Dong H., Prestwich E.G., Shi P.Y., Preiser P.R., Alonso S., Dedon P.C. A multidimensional platform for the purification of non-coding RNA species. Nucleic Acids Res. 2013, 41:e168.
69. Kariko K., Muramatsu H., Ludwig J., Weissman D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 2011, 39:e142.
70. Booy E.P., Meng H., McKenna S.A. Recombinant and In Vitro RNA Synthesis 2012, 69-81. G.L. Conn (Ed.).
71. Gjerde D.T., Lee Hoang D. Hornby, RNA Purification and Analysis: Sample Preparation, Extraction, Chromatography 2009, Wiley-VCH Verlag GmbH & Co.
72. Shanagar J. Purification of a synthetic oligonucleotide by anion exchange chromatography: method optimisation and scale-up. J. Biochem. Biophys. Methods 2005, 64:216-225.
73. Thayer J., Murugaiah V., Wu Y. Handbook of Analysis of Oligonucleotides and Related Products 2011, 47-104. CRC Press, Boca Raton, FL. J.V. Bonilla, S.G. Srivatsa (Eds.).
74. Ge Q., McManus M.T., Nguyen T., Shen C.H., Sharp P.A., Eisen H.N., Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2718-2723.
75. Noll B., Seiffert S., Hertel F., Debelak H., Hadwiger P., Vornlocher H.-P., Roehl I. Purification of small interfering RNA using nondenaturing anion-exchange chromatography. Nucleic Acid Therapeutics. 2011, 21:383-393.
76. Thayer J.R., Rao S., Pohl C., Wu Y., Angelino M. Chromatography Today 2011, 28-32. http://www.chromatographytoday.com.
77. Stillian J.R., Pohl C.A. New latex-bonded pellicular anion exchangers with multi-phase selectivity for high-performance chromatographic separations. J. Chromatogr. A 1990, 499:249-266.
78. Thayer J.R., Flook K.J., Woodruff A., Rao S., Pohl C.A. New monolith technology for automated anion-exchange purification of nucleic acids. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2010, 878:933-941.
79. Koubek J., Lin K.F., Chen Y.R., Cheng R.P., Huang J.J. Strong anion-exchange fast performance liquid chromatography as a versatile tool for preparation and purification of RNA produced by in vitro transcription. RNA 2013, 19:1449-1459.
80. Diogo M.M., Queiroz J.A., Prazeres D.M. Chromatography of plasmid DNA. J. Chromatogr. A 2005, 1069:3-22.
81. Sousa Â., Sousa F., Queiroz J.A. Advances in chromatographic supports for pharmaceutical-grade plasmid DNA purification. J. Sep. Sci. 2012, 35:3046-3058.
82. Lowe C.R., Lowe A.R., Gupta G. New developments in affinity chromatography with potential application in the production of biopharmaceuticals. J. Biochem. Biophys. Methods 2001, 49:561-574.
83. Uhlen M. Affinity as a tool in life science. Biotechniques 2008, 44:649-654.
84. Roque A.C., Lowe C.R. Affinity chromatography: history, perspectives, limitations and prospects. Methods Mol. Biol. 2008, 421:1-21.
85. Magdeldin S. A MoserTech. Affinity Chromatography 2012, 1-27. InTech. S. Magdeldin (Ed.).
86. Labrou N.E. Design and selection of ligands for affinity chromatography. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2003, 790:67-78.
87. Sousa F., Prazeres D.M., Queiroz J.A. Affinity chromatography approaches to overcome the challenges of purifying plasmid DNA. Trends Biotechnol. 2008, 26:518-525.
88. Ayyar B.V., Arora S., Murphy C., O'Kennedy R. Affinity chromatography as a tool for antibody purification. Methods 2012, 56:116-129.
89. Moore P.B. Structural motifs in RNA. Annu. Rev. Biochem 1999, 68:287-300.
90. Aviv H., Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Natl. Acad. Sci. U. S. A. 1972, 69:1408-1412.
91. Ruby S.W., Goelz S.E., Hostomsky Z., Abelson J.N. Affinity chromatography with biotinylated RNAs. Methods Enzymol. 1990, 181:97-121.
92. Kyte J.A., Kvalheim G., Aamdal S., Saeboe-Larssen S., Gaudernack G. Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination. Cancer Gene Ther. 2005, 12:579-591.
93. Wendisch V.F., Zimmer D.P., Khodursky A., Peter B., Cozzarelli N., Kustu S. Isolation of Escherichia coli mRNA and comparison of expression using mRNA and total RNA on DNA microarrays. Anal. Biochem. 2001, 290:205-213.
94. Srisawat C., Engelke D.R. RNA affinity tags for purification of RNAs and ribonucleoprotein complexes. Methods 2002, 26:156-161.
95. Ponchon L., Dardel F. Large scale expression and purification of recombinant RNA in Escherichia coli. Methods 2011, 54:267-273.
96. Srisawat C., Goldstein I.J., Engelke D.R. Sephadex-binding RNA ligands: rapid affinity purification of RNA from complex RNA mixtures. Nucleic Acids Res. 2001, 29:E4.
97. Srisawat C., Engelke D.R. Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins. RNA 2001, 7:632-641.
98. Walker S.C., Scott F.H., Srisawat C., Engelke D.R. RNA affinity tags for the rapid purification and investigation of RNAs and RNA-protein complexes. Methods Mol. Biol. 2008, 488:23-40.
99. Batey R.T., Kieft J.S. Improved native affinity purification of RNA. RNA 2007, 13:1384-1389.
100. Martins R., Queiroz J.A., Sousa F. A new affinity approach to isolate Escherichia coli 6S RNA with histidine-chromatography. J. Mol. Recognit. 2010, 23:519-524.
101. Martins R., Queiroz J.A., Sousa F. Histidine affinity chromatography-based methodology for the simultaneous isolation of Escherichia coli small and ribosomal RNA. Biomed. Chromatogr. 2012, 26:781-788.
102. Sousa F., Cruz C., Queiroz J.A. Amino acids-nucleotides biomolecular recognition: from biological occurrence to affinity chromatography. J. Mol. Recognit. 2010, 23:505-518.
103. Treger M., Westhof E. Statistical analysis of atomic contacts at RNA-protein interfaces. J. Mol. Recognit. 2001, 14:199-214.
104. Yarus M., Widmann J.J., Knight R. RNA-amino acid binding: a stereochemical era for the genetic code. J. Mol. Evol. 2009, 69:406-429.
105. Jeong E., Kim H., Lee S.W., Han K. Discovering the interaction propensities of amino acids and nucleotides from protein-RNA complexes. Mol. Cells 2003, 16:161-167.
106. Vijayalakshmi M.A. Histidine ligand affinity chromatography. Mol. Biotechnol. 1996, 6:347-357.
107. Sousa F., Freitas S., Azzoni A.R., Prazeres D.M., Queiroz J.A. Selective purification of supercoiled plasmid DNA from clarified cell lysates with a single histidine-agarose chromatography step. Biotechnol. Appl. Biochem. 2006, 45:131-140.
108. Sousa F., Matos T., Prazeres D.M.F., Queiroz J.A. Specific recognition of supercoiled plasmid DNA in arginine affinity chromatography. Anal. Biochem. 2008, 374:432-434.
109. Sousa F., Prazeres D.M., Queiroz J.A. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography. J. Gene Med. 2009, 11:79-88.
110. Wang W.X., Wilfred B.R., Baldwin D.A., Isett R.B., Ren N., Stromberg A., Nelson P.T. Focus on RNA isolation: obtaining RNA for microRNA (miRNA) expression profiling analyses of neural tissue. Biochim. Biophys. Acta 2008, 1779:749-757.
111. Özkara S., Yavuz H., Pat r S., Ar ca M.Y., Denizli A. Separation of human-immunoglobulin-G from human plasma with L-histidine immobilized pseudo-specific bioaffinity adsorbents. Sep. Sci. Technol. 2002, 37:717-731.
112. Pitiot O., Vijayalakshmi M.A. Biochromatography: Theory and Practice 2002, Taylor & Francis Inc., New York.
113. Martins R., Maia C.J., Queiroz J.A., Sousa F. A new strategy for RNA isolation from eukaryotic cells using arginine affinity chromatography. J. Sep. Sci. 2012, 35:3217-3226.
114. Nelissen F.H., Leunissen E.H., van de Laar L., Tessari M., Heus H.A., Wijmenga S.S. Fast production of homogeneous recombinant RNA - towards large-scale production of RNA. Nucleic Acids Res. 2012, 40:e102.
115. Cart G., Jungbauer A. Protein Chromatography. Process Development and Scale-Up 2010, Wiley-VCH Verlag GmbH & Co.
116. Ferreira G.N., Cabral J.M., Prazeres D.M. Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications. Biotechnol. Progr. 1999, 15:725-731.
117. Martins R., Queiroz J.A., Sousa F. New approach in RNA quantification using arginine-affinity chromatography: potential application in eukaryotic and chemically synthesized RNA. Anal. Bioanal. Chem. 2013, 405:8849-8858.
118. Tenson T., Mankin A. Antibiotics and the ribosome. Mol. Microbiol. 2006, 59:1664-1677.
119. van Raam B.J., Salvesen G.S. Transferring death: a role for tRNA in apoptosis regulation. Mol. Cell 2010, 37:591-592.
120. Belostotsky R., Frishberg Y., Entelis N. Human mitochondrial tRNA quality control in health and disease: a channelling mechanism?. RNA Biol 2012, 9:33-39.
121. Matera A.G., Terns R.M., Terns M.P. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat. Rev. Mol. Cell Biol. 2007, 8:209-220.
122. Kiss T. Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J. 2001, 20:3617-3622.
123. Dias N., Stein C.A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 2002, 1:347-355.
124. Brantl S. Antisense-RNA regulation and RNA interference. Biochim. Biophys. Acta 2002, 1575:15-25.
125. Kusenda B., Mraz M., Mayer J., Pospisilova S. MicroRNA biogenesis, functionality and cancer relevance. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2006, 150:205-215.
126. Lin S.L., Miller J.D., Ying S.Y. Intronic microRNA (miRNA). J. Biomed. Biotechnol. 2006, 2006:26818.
127. Doench J.G., Petersen C.P., Sharp P.A. siRNAs can function as miRNAs. Genes Dev. 2003, 17:438-442.
128. Ghildiyal M., Zamore P.D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 2009, 10:94-108.
129. Phylactou L.A., Kilpatrick M.W., Wood M.J. Ribozymes as therapeutic tools for genetic disease. Hum. Mol. Genet. 1998, 7:1649-1653.
130. Tucker B.J., Breaker R.R. Riboswitches as versatile gene control elements. Curr. Opin. Struct. Biol. 2005, 15:342-348.
131. Blount K.F., Breaker R.R. Riboswitches as antibacterial drug targets. Nat. Biotechnol. 2006, 24:1558-1564.
132. Mayer G. The chemical biology of aptamers. Angew. Chem. Int. Ed. Engl. 2009, 48:2672-2689.
133. Ni X., Castanares M., Mukherjee A., Lupold S.E. Nucleic acid aptamers: clinical applications and promising new horizons. Curr. Med. Chem. 2011, 18:4206-4214.